Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma

This study has suspended participant recruitment.
Sponsor:
Information provided by:
SOLX, Inc.
ClinicalTrials.gov Identifier:
NCT00382395
First received: September 27, 2006
Last updated: September 17, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)